Oct 2025 $2 M Private placement after listing $2 to $10 million 1
Celularity Inc: Private sale, Oct 2025 × Investors in this round 1 investor had bought by the notice of Nov 3, 2025: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $7 M offered; $5 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John R. Haines · Executive Officer · Senior Executive Vice President, Chief Administrative Officer and Corporate Secretary Joseph R. DosSantos · Executive Officer · Interim Chief Financial Officer Robert J. Hariri · Executive Officer, Director · Chief Executive Officer and Chairman of the Board of Directors Stephen A. Brigido · Executive Officer · President, Degenerative Disease Diane A. Parks · Director Geoffrey A. Ling · Director Peter A. Diamandis · Director Vincent A. LeVien · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Robert J. Hariri, Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 3, 2025. Read the notice at the SEC .
equity, options SEC Jul 2025 $2 M Private placement after listing $2 to $10 million 1
Celularity Inc: Private sale, Jul 2025 × Investors in this round 1 investor had bought by the notice of Aug 5, 2025: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John R. Haines · Executive Officer · Senior Executive Vice President, Chief Administrative Officer and Corporate Secretary Joseph R. DosSantos · Executive Officer · Chief Financial Officer Robert J. Hariri · Executive Officer, Director · Chief Executive Officer and Chairman of the Board of Directors Stephen A. Brigido · Executive Officer · President, Degenerative Disease Diane A. Parks · Director Geoffrey A. Ling · Director Peter A. Diamandis · Director Vincent A. LeVien · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Robert J. Hariri, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 5, 2025. Read the notice at the SEC .
equity, options SEC Jul 2025 $1 M Private placement after listing Under $2 million 14
Celularity Inc: Private sale, Jul 2025 × Investors in this round 14 investors had bought by the notice of Aug 5, 2025: 14 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John R. Haines · Executive Officer · Senior Executive Vice President, Chief Administrative Officer and Corporate Secretary Joseph R. DosSantos · Executive Officer · Chief Financial Officer Robert J. Hariri · Executive Officer, Director · Chief Executive Officer and Chairman of the Board of Directors Stephen A. Brigido · Executive Officer · President, Degenerative Disease Diane A. Parks · Director Geoffrey A. Ling · Director Peter A. Diamandis · Director Vincent A. LeVien · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Robert J. Hariri, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 5, 2025. Read the notice at the SEC .
equity, options SEC Jul 2025 $7 M Private placement after listing $2 to $10 million 1
Celularity Inc: Private sale, Jul 2025 × Investors in this round 1 investor had bought by the notice of Aug 5, 2025: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $7 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice John R. Haines · Executive Officer · Senior Executive Vice President, Chief Administrative Officer and Corporate Secretary Joseph R. DosSantos · Executive Officer · Chief Financial Officer Robert J. Hariri · Executive Officer, Director · Chief Executive Officer and Chairman of the Board of Directors Stephen A. Brigido · Executive Officer · President, Degenerative Disease Diane A. Parks · Director Geoffrey A. Ling · Director Peter A. Diamandis · Director Vincent A. LeVien · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Robert J. Hariri, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 5, 2025. Read the notice at the SEC .
debt, options SEC May 2022 $30 M Private placement after listing $10 to $50 million 1
Celularity Inc: Private sale, May 2022 × Investors in this round 1 investor had bought by the notice of May 27, 2022: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $30 M of $30 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $2,100,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andrew L. Pecora · Executive Officer Anne R. Jones · Executive Officer Bradley A. Glover · Executive Officer David C. Beers · Executive Officer John R. Haines · Executive Officer Keary A. Dunn · Executive Officer Robert J. Hariri · Executive Officer, Director Stephen A. Brigido · Executive Officer Andrew C. von Eschenbach · Director Dean C. Kehler · Director Jay R. Bloom · Director John R. Sculley · Director Lim Kok Thay · Director Marc Kok Mazur · Director Peter R. Diamandis · Director Robin L. Smith · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round A.G.P/ Alliance Global Partners (CRD 8361) · New York, New York Sold in NY Signed by David Beers, Chief Financial Officer. Source: SEC Form D, newest notice filed May 27, 2022. Read the notice at the SEC .
equity, options SEC